<DOC>
	<DOCNO>NCT01685931</DOCNO>
	<brief_summary>The purpose study ass effectiveness , safety tolerability flexibly dose paliperidone palmitate patient schizophrenia previously unsuccessfully treated oral antipsychotic acute symptom schizophrenia .</brief_summary>
	<brief_title>A Study Paliperidone Palmitate Patients With Schizophrenia Previously Unsuccessfully Treated Oral Antipsychotics</brief_title>
	<detailed_description>This 13-week , open-label ( people know identity intervention ) , single-arm ( one group patient ) , multicenter , prospective , interventional study Chinese patient . In prospective , interventional study , patient identify receive treatment course research study follow forward time outcome study . In China , still insufficient information effectiveness , tolerability , dosage strategy directly switch previous oral antipsychotic ( drug helpful treatment psychosis capacity ameliorate think disorder ) patient acute symptom . Acute symptom quick severe form illness early stage . In addition , also lack information bridge acute phase long-term treatment . In study , patient multiple type acute schizophrenia recruit receive Sustenna ( paliperidone palmitate ) treatments 13 week . After acute treatment , patient continue receive prescribe medication follow additional 52 week assess outcomes related long-term treatment .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Previous diagnosis schizophrenia Experiencing acute episode , Positive Negative Syndrome Scale ( PANSS ) total score 70 120 , inclusive Patients currently treat antipsychotic allow recruit Be medically stable basis clinical laboratory test perform screen A primary diagnosis schizophrenia History risperidone paliperidone resistance define failure respond 2 adequate treatment period Clozapine use treatment refractory schizophrenia Relevant history current presence significant unstable condition , disease illness could limit participation study accord investigator Woman pregnant , breastfeeding , plan become pregnant within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Paliperidone Palmitate</keyword>
	<keyword>Oral Antipsychotics</keyword>
	<keyword>Invega Sustenna</keyword>
</DOC>